Search results
AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung...
Benzinga via Yahoo Finance· 7 hours agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) released topline data from the ADJUVANT BR.31 Phase 3...
AstraZeneca makes another obesity play funnelling $80m into SixPeaks Bio
Clinical Trials Arena via Yahoo Finance· 5 hours agoAstraZeneca has committed to $80m in non-dilutive funding to Swiss biotech SixPeak Bio, which is...
AstraZeneca’s trial of Imfinzi for lung cancer failed to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 10 hours agoUK-based pharmaceutical company AstraZeneca has reported high-level results from the ADJUVANT BR.31...
AstraZeneca's Imfinzi fails in late-stage trial to treat certain type of lung cancer
Reuters· 14 hours agoAstraZeneca said on Tuesday its blockbuster cancer drug, Imfinzi, failed to improve disease-free survival in a late-stage trial to treat a type of early-stage lung cancer.
BenevolentAI says second target identified by AstraZeneca collaboration
Proactive Investors· 14 hours agoBenevolentAI (OTC:BAIVF) said that AstraZeneca PLC (LSE:AZN) has identified a target for systemic...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoWhat do you get when you combine a low share price, an attractive valuation, better growth prospects than meet the eye, and a juicy dividend yield? My...
AstraZeneca (LON:AZN) Given Hold Rating at Deutsche Bank Aktiengesellschaft
ETF DAILY NEWS· 7 days agoDeutsche Bank Aktiengesellschaft reiterated their hold rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report sent to investors on Tuesday, MarketBeat.com ...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 hours agoPublished exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0348 ET – AstraZeneca’s cancer-drug Imfinzi positive results from...
AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer
Zacks via Yahoo Finance· 5 days agoThe European Commission approves AstraZeneca's (AZN) Truqap in combination with Faslodex for...
AstraZeneca’s Truqap flops in Phase III triple negative breast cancer trial
Clinical Trials Arena via Yahoo Finance· 6 days agoAstraZeneca has been dealt a blow after its flagship breast cancer drug Truqap (capivasertib) did...